全球大肠直肠癌诊断市场规模、份额、趋势和成长分析报告（2026-2034年）

预计大肠直肠癌诊断市场将从 2025 年的 201.4 亿美元成长到 2034 年的 359.8 亿美元，2026 年至 2034 年的复合年增长率为 6.66%。

由于全球大肠直肠癌发生率不断上升，全球大肠癌诊断市场正在扩张。人口老化、久坐的生活方式和饮食习惯的改变显着增加了大肠癌的发病率，导致对早期检测和筛检解决方案的需求日益增长。政府推行的定期体检和健康宣传活动也促进了市场成长。

分子诊断、生物标记检测以及粪便大便潜血试验等非侵入性筛检方法的技术进步正在改变诊断格局。更高的准确性、更快的检测结果报告以及微创操作提高了患者的依从性。此外，人工智慧在影像学和病理诊断中的应用也提高了检出率并减少了诊断错误。

受精准医疗和个人化治疗方案日益普及的推动，市场前景依然强劲。开发中国家医疗基础设施的扩张和研发投入的增加将进一步加速市场成长。家用筛检盒和数位健康平台的普及也有望提高医疗服务的可近性，并改善早期诊断效果。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球大肠直肠癌诊断市场：依检测类型划分

• 市场分析、洞察与预测
• 验血
• 粪便检验
• 影像检查（CT、超音波、MRI、PET）
• 切片检查
• 其他测试方法

第五章：全球大肠直肠癌诊断市场：依最终用途划分

• 市场分析、洞察与预测
• 医院
• 诊断影像中心
• 癌症研究中心
• 其他最终用途

第六章 全球大肠直肠癌诊断市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 亚太其他地区
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第七章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第八章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Danaher Corporation
  • DiaCarta
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche
  • GE HealthCare Technologies
  • Geneoscopy
  • Guardant Health
  • HU Group Holdings
  • New Day Diagnostics
  • Olympus Corporation
  • Phase Scientific International
  • QIAGEN NV
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific

The Colorectal Cancer Diagnostics Market size is expected to reach USD 35.98 Billion in 2034 from USD 20.14 Billion (2025) growing at a CAGR of 6.66% during 2026-2034.

The global colorectal cancer diagnostics market is expanding due to the rising prevalence of colorectal cancer worldwide. Aging populations, sedentary lifestyles, and dietary changes have significantly increased the incidence rate, driving demand for early detection and screening solutions. Government initiatives promoting regular screenings and awareness campaigns are also contributing to market growth.

Technological advancements in molecular diagnostics, biomarker-based testing, and non-invasive screening methods such as fecal immunochemical tests are transforming the diagnostic landscape. Improved accuracy, faster turnaround times, and minimally invasive procedures are enhancing patient compliance. Additionally, integration of artificial intelligence in imaging and pathology is improving detection rates and reducing diagnostic errors.

Future prospects remain strong as precision medicine and personalized treatment approaches gain traction. Expansion of healthcare infrastructure in developing countries and growing investments in research and development will further accelerate market growth. Increasing adoption of home-based screening kits and digital health platforms is also expected to expand access and improve early diagnosis outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Test Type

• Blood Tests
• Stool Tests
• Imaging Tests (CT, Ultrasound, MRI, PET)
• Biopsy
• Other Test Types

By End Use

• Hospitals
• Diagnostic Imaging Centers
• Cancer Research Centers
• Other End Use

COMPANIES PROFILED

• Danaher Corporation, DiaCarta, Exact Sciences Corporation, F HoffmannLa Roche, GE HealthCare Technologies, Geneoscopy, Guardant Health, HU Group Holdings, New Day Diagnostics, Olympus Corporation, Phase Scientific International, QIAGEN NV, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Test Type
• 4.2. Blood Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Stool Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Imaging Tests (CT, Ultrasound, MRI, PET) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Test Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY END USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End Use
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Diagnostic Imaging Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Cancer Research Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Other End Use Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Test Type
  • 6.2.2 By End Use
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Test Type
  • 6.3.2 By End Use
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Test Type
  • 6.4.2 By End Use
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Test Type
  • 6.5.2 By End Use
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Test Type
  • 6.6.2 By End Use
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL COLORECTAL CANCER DIAGNOSTICS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Danaher Corporation
  • 8.2.2 DiaCarta
  • 8.2.3 Exact Sciences Corporation
  • 8.2.4 F. Hoffmann-La Roche
  • 8.2.5 GE HealthCare Technologies
  • 8.2.6 Geneoscopy
  • 8.2.7 Guardant Health
  • 8.2.8 H.U. Group Holdings
  • 8.2.9 New Day Diagnostics
  • 8.2.10 Olympus Corporation
  • 8.2.11 Phase Scientific International
  • 8.2.12 QIAGEN N.V
  • 8.2.13 Siemens Healthineers
  • 8.2.14 Sysmex Corporation
  • 8.2.15 Thermo Fisher Scientific